Clinical Trials for Thymic Carcinoma

Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT ID: NCT03556228

This clinical trial is studying a new medication called VMD-928, which is being tested for patients with certain types of advanced cancers and lymphomas that have not responded to standard treatmen...

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

NCT ID: NCT03076554

This clinical trial is looking at a new treatment option called Avelumab for patients with thymoma or thymic carcinoma, which are types of cancer that start in the thymus gland. The study aims to f...

Molecular Analysis and Treatment Options of Thymic Malignancies

NCT ID: NCT05667948

This clinical trial is focused on understanding thymic malignancies, which are cancers that occur in the front part of the chest. While surgery and radiation can help many patients, some still face...

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

NCT ID: NCT03463460

This clinical trial is exploring the effectiveness of two medications, pembrolizumab and sunitinib malate, in treating thymic carcinoma that has spread to other parts of the body or cannot be surgi...

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

NCT ID: NCT06248515

This clinical trial is investigating a medication called sacituzumab govitecan for adults with advanced thymoma and thymic carcinoma, which are rare types of tumors originating in the thymus gland....

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

NCT ID: NCT06838910

This clinical trial is studying a new treatment approach for patients with thymoma and thymic carcinoma who have not responded well to their initial chemotherapy. The trial will test a combination ...

Molecular Analysis of Thoracic Malignancies

NCT ID: NCT01385722

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

NCT ID: NCT06402708

The FUSCC-Thymic 3 clinical trial is studying how effective a type of chemotherapy is for patients with thymic carcinoma after they have had surgery to remove the tumor. The main goals are to find ...

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

NCT ID: NCT06301945

This clinical trial is focused on improving the diagnosis and treatment of thymic epithelial tumors, which are rare types of tumors found in the chest. The researchers are developing a tool that us...

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

NCT ID: NCT06019468

This clinical trial is studying a new treatment approach for patients with locally advanced thymic carcinoma, a type of cancer that starts in the thymus gland. The researchers want to find out if a...